Bessemer Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-33
Closed -$3K 2078
2022
Q1
$3K Hold
33
﹤0.01% 1704
2021
Q4
$5K Hold
33
﹤0.01% 1605
2021
Q3
$6K Hold
33
﹤0.01% 1494
2021
Q2
$5K Hold
33
﹤0.01% 1436
2021
Q1
$6K Buy
+33
New +$6K ﹤0.01% 1384